Survival benefit from response-guided approach: a direct effect of more effective cytotoxic regimens or an indirect effect of chemotherapy-induced amenorrhea? Reply to K.-D. Yu et al
J Clin Oncol
.
2014 Apr 20;32(12):1283-4.
doi: 10.1200/JCO.2013.54.4437.
Epub 2014 Mar 17.
Authors
Gunter von Minckwitz
1
,
Sibylle Loibl
Affiliation
1
German Breast Group, Neu-Isenburg; University Hospital Frankfurt, Frankfurt, Germany.
PMID:
24638006
DOI:
10.1200/JCO.2013.54.4437
No abstract available
Publication types
Letter
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Breast Neoplasms / drug therapy*
Female
Humans
Neoadjuvant Therapy*